Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿ä¹èÃâ½Ã ¿äµµÃⱸÀÇ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ½Å°æÀμº ¿ä¼Ò¿¡ ´ëÇÑ µ¿¹° ½ÇÇè: ¿äµµ È®Àå¿¡ ÀÖ¾î Nitric Oxide ¹× º£Å¸ ±³°¨ ½Å°æüÀÇ ÀÛ¿ë Neural Factors Controlling Urethral Outlet Activity in vivo: Role of Nitric Oxide and ¥â-Adrenergic System in Urethral Relaxation

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 9È£ p.912 ~ 920
Àüº´±Ô, ¹ÚÈì·Ê,
¼Ò¼Ó »ó¼¼Á¤º¸
Àüº´±Ô (  ) 
°í·Á´ëÇб³

¹ÚÈì·Ê (  ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

°á·Ð
Urethane ¸¶ÃëÇÏÀÇ ÈòÁ㸦 ÀÌ¿ëÇÑ ¹æ±¤ ¹× ¿äµµ¾Ð·ÂÃøÁ¤¿¡¼­ ÈòÁãÀÇ ¹æ±¤Àº ¹è´¢¹Ý»ç¸¦
À¯¹ßÇÏ´Â ÀÏÁ¤ÇÑ ¹æ±¤¿ëÀû ÀÌ»óÀÇ ¿ä·®¿¡ µµ´ÞÇÏ¸é ¹Ý»çÀû ¹æ±¤¼öÃàÀÌ ³ªÅ¸³ª¸ç ÀÌ¿Í µ¿½Ã
¿¡ ¿äµµ°ý¾à±ÙÀº ¹Ý»çÀû ÀÌ¿ÏÀ» ÇÏ¿© Á¶È­·Î¿î ¹è´¢°úÁ¤À» ¼öÇàÇÏ´Â °ÍÀ» È®ÀÎÇÏ¿´´Ù. À̶§
¿äµµÀÇ ÀÌ¿Ï¿¡ °ü¿©ÇÏ´Â ÀÎÀڷμ­ NO°æ·Î°¡ ¹è´¢½Ã ¿äµµÆòÈ°±ÙÀÇ ¹Ý»çÀû ÀÌ¿ÏÀ» ¼öÇàÇϸç
º£Å¸ ±³°¨½Å°æµµ NO°æ·Î¿Í ÇÔ²² ¿äµµÀÇ À̿ϹÝÀÀ¿¡ °ü¿©ÇÔÀ» ¾Ë ¼ö ÀÖ¾ú´Ù. ¾ËÆÄ ±³°¨½Å°æ
Àº ¾ÈÁ¤½Ã ¿äµµÆòÈ°±ÙÀÇ ±äÀåÀ» À¯ÁöÇÏ¿© ¿äÀÚÁ¦¸¦ À¯ÁöÇÏ¸ç ¾ËÆÄ ±³°¨Á¦ Åõ¿©½Ã ¹Ý»çÀû ¿ä
µµÀÌ¿Ï °úÁ¤ÀÌ Â÷´ÜµÊÀ» ¾Ë ¼ö ÀÖ¾ú´Ù.
#ÃÊ·Ï#
Aims of Study: During reflex micturition, the urethral outlet remains open (relaxed) to
promote urinary emptying. The mechanisms involved in the relaxation of urethral outlet
is thought to be complex including nitric oxide (NO) pathway and ¥â-adrenergic
activity. The aims of the study focused on these several issues related to the neural
control of urethral outlet in vivo.
Materials & Methods: Female rats weighing 200¡­300 gm were anesthetized wish
urethane. Catheters were inserted into femoral artery for drug administration.4 two-way
catheter (16 G angiocath) was inserted into the bladder for saline infusion and pressure
monitoring. A separate cannula (PE 50) was placed into the urethra via external urethral
meatus or proximal urethrat opening to record urethral pressure. The bladder was filled
with saline at a rate of 0.1 §¢/min to induce reflex micturition. Urethral pressure was
recorded via cannula through which saline was infused at a rate of 0.05 §¢/min.
Isovolumetric bladder contraction and urethral pressure were recorded simultaneously.
After an equilibration period of 30 minutes, baseline intravesical and urethral pressure
were recorded for 10 minutes prior to drug administration.
NG-nitro-L-arginine methylester (L-NAME, 10 to 15 §·/§¸, i.v.),
L-arginine (150 §·/§¸, i.v.), propranolol (1 uM., 0.1 §¢/250 §·, i.a.), and phenylephrine (1
0¡­100 uM, i.a.) were administrated.
Results: During isovolumetric bladder contraction, urethral pressure was decreased
simultaneously, and then returned to the resting states in conjunction with end of the
bladder contraction. After the administration of L-NAME, the magnitude of reflex
urethral relaxation was decreased significantly (42.6 ¡¾ 15.1% of the control, p<0.01),
and this effect was reversed by addition of L-arginine. Administration of propranolol
also inhibited urethral relaxation (66.4% of the control). Administration of L-NAME
followed by propranolol almost completely abolished the urethral relaxation.
Administration of phenylephrine increased the resting urethral tone (mean; 4
cmH2O) significantly, and the magnitude of urethral relaxation was
decreased substantially.
Conclusion: These results suggest that urethral relaxation is mediated by several
neural factors. NO seems like to a potent mediator in a reflex relaxation of the urethral
smooth muscle during micturition. Also, ¥â-adrenergic stimulation play an important role
for urethral relaxation. ¥á-adrenergic nerve discharge, contributed to contraction of
urethral smooth muscle, shows inhibitory effect against the reflex urethral relaxation.

Å°¿öµå

Urethral relaxation; Nitric oxide; ¥â-adrenergics;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS